PMTA and MRTP: navigating the path to FDA approval for reduced-risk products

As PMI’s iQOS comes under consideration by the US FDA, we examine the hurdles it – and other – heated tobacco and e-cigarette products will have to clear to obtain authorisation for commercialisation and reduced-risk claims. ...

Restricted content. Do you want to read more?